Gain Therapeutics (GANX) Other Working Capital Changes (2020 - 2026)

Gain Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at $215108.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 47.34% year-over-year to $215108.0 in Q2 2026; TTM through Jun 2026 was -$890187.0, a 197.47% decrease from a year earlier, with the FY2025 full-year figure at -$130568.0, down 136.61% from the prior year.
• Other Working Capital Changes was $215108.0 for Q2 2026 at Gain Therapeutics, down from $278213.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.9 million in Q3 2024, with the low at -$1.4 million in Q2 2023.
• Average Other Working Capital Changes over 5 years is $33413.9, with a median of -$76798.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 201.8% in 2024, then tumbled 3920.25% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$271563.0 in 2022, then jumped by 89.19% to -$29360.0 in 2023, then sank by 1133.99% to -$362298.0 in 2024, then sank by 42.73% to -$517113.0 in 2025, then jumped by 141.6% to $215108.0 in 2026.
• The last three Other Working Capital Changes figures came in at $215108.0 (Q2 2026), $278213.0 (Q1 2026), and -$517113.0 (Q4 2025), per Business Quant data.